Jae-Hoon Ko
Overview
Explore the profile of Jae-Hoon Ko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
97
Citations
1348
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang J, Baek J, Ko J, Huh K, Cho S, Chung D, et al.
Microbiol Spectr
. 2025 Jan;
13(2):e0160424.
PMID: 39745431
Carbapenem-resistant complex (CR-ECC), which is rapidly increasing as the cause of nosocomial infections, has limited treatment options. The aim of this study is to investigate the microbiological and clinical traits...
2.
Kim S, Kim H, Chung D, Ko J, Huh K, Cho S, et al.
J Antimicrob Chemother
. 2024 Dec;
80(3):738-745.
PMID: 39737887
Background: Our research aimed to investigate the potential of in vitro triple antimicrobial synergism against carbapenem-resistant Pseudomonas aeruginosa (CRPA) as a strategy to overcome antimicrobial resistance. Methods: We used 12...
3.
Kang H, Kim H, Jung J, Ahn J, Song K, Baek J, et al.
J Infect Dis
. 2024 Nov;
231(2):392-402.
PMID: 39612911
Background: With the transition from the coronavirus disease 2019 (COVID-19) pandemic into endemicity, changes in group immunity and the effect of updated XBB.1.5 monovalent vaccine (MonoV) need to be investigated....
4.
Gerelkhuu Z, Park S, Lee K, Kim Y, Kwon S, Song K, et al.
Immun Ageing
. 2024 Jul;
21(1):51.
PMID: 39080742
Background: Age-dependent immune responses to coronavirus disease 2019 (COVID-19) vaccinations and breakthrough infections (BIs) in young and middle-aged individuals are unclear. Methods: This nationwide multicenter prospective cohort study analyzed immune...
5.
Ko J, Kim C, Bang M, Lee D, Kim D, Seo J, et al.
Vaccines (Basel)
. 2024 Jul;
12(7).
PMID: 39066390
We aimed to identify the risk factors for impaired cellular and humoral immunity after three doses of the SARS-CoV-2 vaccine. Six months after the third vaccine dose, T-cell immunity was...
6.
Nham E, Kim S, Ko J, Huh K, Cho S, Kang C, et al.
Med Mycol
. 2024 Jul;
62(8).
PMID: 39030069
We evaluated the diagnostic performance of the β-d-glucan (BDG) test (Beijing Gold Mountain River Tech) in diagnosing invasive fungal disease (IFD) and its variations among patients with different risks. Patients ...
7.
Choi S, Lee W, Kim S, Jo H, Park H, Kim H, et al.
Vaccine
. 2024 Jul;
42(25):126118.
PMID: 39025696
Among new vaccine technologies contributed to the control of the COVID-19 pandemic, ChAdOx1 nCoV-19, a chimpanzee adenovirus (ChAd)-vector vaccine expressing the SARS-CoV-2 spike protein, could be administered globally owing to...
8.
Lee K, Song K, Lee K, Baek J, Kim E, Song Y, et al.
Vaccine
. 2024 May;
42(19):3953-3960.
PMID: 38729909
Introduction: The long-term impact of initial immunogenicity induced by different primary COVID-19 vaccine series remains unclear. Methods: A prospective cohort study was conducted at 10 tertiary hospitals in Korea from...
9.
Kang M, Baek J, Ko J, Cho S, Lee K, Lee Y, et al.
Microbiol Spectr
. 2024 Apr;
12(6):e0034424.
PMID: 38687076
Importance: This study investigated 188 carbapenemase (KPC)-2-producing Enterobacterales collected from January 2020 to June 2023 in a tertiary care hospital of Korea. Most isolates were susceptible to ceftazidime-avibactam (98.9%) and...
10.
Kim S, Kim J, Jung S, Noh J, Kim J, Park H, et al.
Sci Immunol
. 2024 Jan;
9(91):eade6132.
PMID: 38241400
Here, we examine peripheral blood memory T cell responses against the SARS-CoV-2 BA.4/BA.5 variant spike among vaccinated individuals with or without Omicron breakthrough infections. We provide evidence supporting a lack...